Effective August 1, 2024, this database was discontinued. All content will remain searchable and be preserved online for historical purposes only until 2029.
Angioimmunoblastic T-cell Lymphoma
What's New
Last Posted: Jun 14, 2024
- Single-cell landscape reveals the immune heterogeneity of bone marrow involvement in peripheral T-cell lymphoma.
Jun Liu, et al. Cancer science 2024 0 - Clonal hematopoiesis and bone marrow infiltration in patients with follicular helper T-cell lymphoma of angioimmunoblastic type.
Lennart Harland, et al. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2024 0 100519 - [Mutation characteristics of angioimmunoblastic T-cell lymphoma: an analysis of 75 cases].
X Shen, et al. Zhonghua bing li xue za zhi = Chinese journal of pathology 2024 0 (1) 29-33 - Angioimmunoblastic T-cell lymphoma: Novel recurrent mutations and prognostic biomarkers by cell-free DNA profiling.
Chunlan Zhang, et al. British journal of haematology 2023 0 - Multiple Ways to Detect IDH2 Mutations in Angioimmunoblastic T-Cell Lymphoma from Immunohistochemistry to Next-Generation Sequencing.
Dupuy Aurélie, et al. The Journal of molecular diagnostics : JMD 2018 0 (5) 677-685 - A Survey of Somatic Mutations in 41 Genes in a Cohort of T-Cell Lymphomas Identifies Frequent Mutations in Genes Involved in Epigenetic Modification.
Fernandez-Pol Sebastian, et al. Applied immunohistochemistry & molecular morphology : AIMM 2018 0 (6) 416-422 - Angioimmunoblastic T-cell lymphoma in Taiwan reveals worse progression-free survival for RHOA G17V mutated subtype.
Hsu Ya-Ting, et al. Leukemia & lymphoma 2019 0 (5) 1108-1118 - Droplet digital polymerase chain reaction assay and peptide nucleic acid-locked nucleic acid clamp method for RHOA mutation detection in angioimmunoblastic T-cell lymphoma.
Tanzima Nuhat Sharna, et al. Cancer science 2018 0 (5) 1682-1689 - [Angioimmunoblastic T-cell lymphoma: histopathological grading and prognosis].
Guo Y M, et al. Zhonghua bing li xue za zhi = Chinese journal of pathology 2019 0 (10) 784-790 - The pathological features of angioimmunoblastic T-cell lymphomas with IDH2 mutations.
Steinhilber Julia, et al. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2019 0 (8) 1123-1134 - Combination treatment of copanlisib and gemcitabine in relapsed/refractory PTCL (COSMOS): an open-label phase I/II trial.
Yhim H-Y, et al. Annals of oncology : official journal of the European Society for Medical Oncology 2020 0 (4) 552-559 - Clonal hematopoiesis in angioimmunoblastic T-cell lymphoma with divergent evolution to myeloid neoplasms.
Lewis Natasha E, et al. Blood advances 2020 0 (10) 2261-2271 - RHOA mutation in follicular T-cell lymphoma: Clinicopathological analysis of 16 cases.
Miyoshi Hiroaki, et al. Pathology international 2020 0 (9) 653-660 - A computational in silico approach to predict high-risk coding and non-coding SNPs of human PLCG1 gene.
Khan Safayat Mahmud, et al. PloS one 2021 0 (11) e0260054 - Mutation analysis links angioimmunoblastic T-cell lymphoma to clonal hematopoiesis and smoking.
Cheng Shuhua, et al. eLife 2021 0 - Linking the KIR phenotype with STAT3 and TET2 mutations to identify chronic lymphoproliferative disorders of NK cells.
Pastoret Cédric, et al. Blood 2021 0 (23) 3237-3250 - Mutational profiling of circulating tumor DNA and clinical characteristics in lymphoma: Based on next generation sequencing.
Hou Yue, et al. Molecular carcinogenesis 2022 0 (2) 200-209 - Comparison of Epstein-Barr virus-positive mucocutaneous ulcer associated with treated lymphoma or methotrexate in Japan.
Daroontum Teerada, et al. Histopathology 2018 0 (7) 1115-1127 - TET-2 mutations predict poor outcomes and are associated with unfavorable clinical-biological features in PTCL, not otherwise specified and angioimmunoblastic T-cell lymphoma in Brazilian patients.
de Pádua Covas Lage Luís Alberto, et al. Cancer biomarkers : section A of Disease markers 2022 9 - Circulating Tumor DNA-Based Genotyping and Monitoring for Predicting Disease Relapses of Patients with Peripheral T-Cell Lymphomas.
Kim Seok Jin, et al. Cancer research and treatment 2022 3 - Large cell morphology, CMYC+ tumour cells, and PD-1+ tumour cell/intense PD-L1+ cell reactions are important prognostic factors in nodal peripheral T-cell lymphomas with T follicular helper markers.
Mihashi Yasuhito, et al. Diagnostic pathology 2021 11 (1) 101 - Correlation of mutational landscape and survival outcome of peripheral T-cell lymphomas.
Ye Yingying, et al. Experimental hematology & oncology 2021 2 (1) 9 - Integrative analysis of a phase 2 trial combining lenalidomide with CHOP in angioimmunoblastic T-cell lymphoma.
Lemonnier François, et al. Blood advances 2021 1 (2) 539-548 - Multiple mutations at exon 2 of RHOA detected in plasma from patients with peripheral T-cell lymphoma.
Ottolini Barbara, et al. Blood advances 2020 6 (11) 2392-2403 - Peripheral T-Cell Lymphomas: Incorporating New Developments in Diagnostics, Prognostication, and Treatment Into Clinical Practice-PART 2: ENKTL, EATL, Indolent T-Cell LDP of the GI Tract, ATLL, and Hepatosplenic T-Cell Lymphoma.
Zing Natalia Pin Chuen et al. Oncology (Williston Park, N.Y.) 2018 Aug 32(8) - Candidate susceptibility variants in angioimmunoblastic T-cell lymphoma.
Donner Iikki, et al. Familial cancer 2018 8 - A Clinicopathologic Study of Lennert Lymphoma and Possible Prognostic Factors: The Importance of Follicular Helper T-cell Markers and the Association With Angioimmunoblastic T-cell Lymphoma.
Kurita Daisuke, et al. The American journal of surgical pathology 2016 7 - Activating mutations in genes related to TCR signaling in angioimmunoblastic and other follicular helper T-cell-derived lymphomas.
Vallois David, et al. Blood 2016 7 - Response to 5-azacytidine in a patient with TET2-mutated angioimmunoblastic T-cell lymphoma and chronic myelomonocytic leukaemia preceded by an EBV-positive large B-cell lymphoma.
Saillard Colombe, et al. Hematological oncology 2016 6 - Angioimmunoblastic T-cell Lymphomas With the RHOA p.Gly17Val Mutation Have Classic Clinical and Pathologic Features.
Ondrejka Sarah L, et al. The American journal of surgical pathology 2015 11
More
About Rare Diseases PHGKB
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Content Summary
Selected Rare Diseases
Browse full list of rare diseases
A-Z
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Eclampsia
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Glomerulonephritis
- Graves Disease
- Hemophilia
- Huntington Disease
- Microcephaly
- Myasthenia Gravis
- Phenylketonuria
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by Public Health Genomics Branch to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Content source: